Northwest Investment Counselors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.04M Buy
9,978
+229
+2% +$23.3K 0.23% 88
2024
Q2
$946K Sell
9,749
-424
-4% -$39.1K 0.24% 90
2024
Q1
$916K Sell
10,173
-1,492
-13% -$126K 0.22% 90
2023
Q4
$930K Sell
11,665
-6,796
-37% -$511K 0.25% 89
2023
Q3
$1.31M Sell
18,461
-5,817
-24% -$435K 0.37% 74
2023
Q2
$1.87M Sell
24,278
-5,425
-18% -$420K 0.5% 67
2023
Q1
$2.23M Sell
29,703
-5,188
-15% -$386K 0.62% 56
2022
Q4
$2.75M Buy
34,891
+464
+1% +$34.8K 0.79% 35
2022
Q3
$2.42M Sell
34,427
-772
-2% -$60.5K 0.79% 39
2022
Q2
$2.82M Buy
35,199
+1,673
+5% +$131K 0.87% 33
2022
Q1
$2.54M Buy
33,526
+178
+0.5% +$14.1K 0.67% 45
2021
Q4
$2.85M Buy
33,348
+1,367
+4% +$107K 0.7% 47
2021
Q3
$2.42M Buy
31,981
+2,135
+7% +$170K 0.68% 54
2021
Q2
$2.43M Sell
29,846
-121
-0.4% -$9.89K 0.67% 54
2021
Q1
$2.36M Sell
29,967
-504
-2% -$39.5K 0.67% 48
2020
Q4
$2.61M Buy
30,471
+14
+0% +$1.16K 0.81% 40
2020
Q3
$2.35M Sell
30,457
-299
-1% -$22.8K 0.81% 43
2020
Q2
$2.25M Buy
30,756
+676
+2% +$48K 0.87% 38
2020
Q1
$2M Buy
30,080
+2,554
+9% +$180K 0.89% 37
2019
Q4
$1.9M Buy
27,526
+573
+2% +$39.1K 0.67% 52
2019
Q3
$1.98M Sell
26,953
-205
-0.8% -$14.9K 0.7% 50
2019
Q2
$1.95M Buy
27,158
+84
+0.3% +$5.96K 0.72% 47
2019
Q1
$1.86M Buy
27,074
+1,198
+5% +$77.4K 0.72% 50
2018
Q4
$1.54M Buy
25,876
+81
+0.3% +$5.07K 0.67% 53
2018
Q3
$1.73M Sell
25,795
-47
-0.2% -$3.13K 0.66% 50
2018
Q2
$1.68M Sell
25,842
-322
-1% -$21.1K 0.68% 49
2018
Q1
$1.88M Buy
26,164
+147
+0.6% +$10.6K 0.79% 40
2017
Q4
$1.96M Sell
26,017
-34
-0.1% -$2.48K 0.79% 41
2017
Q3
$1.9M Buy
26,051
+427
+2% +$30.8K 0.82% 41
2017
Q2
$1.9M Sell
25,624
-504
-2% -$37.4K 0.86% 38
2017
Q1
$1.91M Buy
26,128
+97
+0.4% +$6.79K 0.92% 35
2016
Q4
$1.7M Buy
26,031
+771
+3% +$52.9K 0.86% 43
2016
Q3
$1.87M Buy
25,260
+382
+2% +$28.2K 0.96% 33
2016
Q2
$1.82M Buy
24,878
+172
+0.7% +$12.2K 0.99% 31
2016
Q1
$1.75M Buy
24,706
+1,503
+6% +$100K 0.99% 31
2015
Q4
$1.55M Buy
23,203
+212
+0.9% +$14.1K 0.95% 38
2015
Q3
$1.46M Buy
22,991
+1,797
+8% +$117K 0.98% 35
2015
Q2
$1.39M Sell
21,194
-410
-2% -$27.8K 0.85% 48
2015
Q1
$1.5M Sell
21,604
-204
-0.9% -$14.1K 0.93% 40
2014
Q4
$1.51M Sell
21,808
-153
-0.7% -$10.3K 0.96% 42
2014
Q3
$1.43M Sell
21,961
-246
-1% -$16.2K 0.96% 42
2014
Q2
$1.51M Sell
22,207
-674
-3% -$45.2K 1.02% 38
2014
Q1
$1.48M Sell
22,881
-462
-2% -$29.1K 1.03% 37
2013
Q4
$1.52M Sell
23,343
-368
-2% -$23.6K 1.06% 36
2013
Q3
$1.41M Sell
23,711
-293
-1% -$17.4K 1.08% 33
2013
Q2
$1.38M Buy
+24,004
New +$1.42M 1.15% 30

Other funds holding CL

Northwest Investment Counselors's CL Position: Q3 2024 in Review

Northwest Investment Counselors increased its Colgate-Palmolive (CL) stake by 2.3% in Q3 2024, buying an estimated $23.3K and bringing the position to 9,978 shares worth $1.04M. The position accounts for 0.23% of the portfolio, ranked #88.

Northwest Investment Counselors first reported a position in CL in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.85M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Northwest Investment Counselors held 9,978 shares of Colgate-Palmolive worth $1.04M as of Q3 2024.
  • Northwest Investment Counselors bought 229 Colgate-Palmolive shares in Q3 2024, an estimated $23.3K.
  • Colgate-Palmolive made up 0.23% of Northwest Investment Counselors's portfolio in Q3 2024, its #88 holding.
  • Northwest Investment Counselors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 46 quarters since.
  • Northwest Investment Counselors's Colgate-Palmolive position peaked at $2.85M in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.